Advertisement

Ads Placeholder
Loading...

StageZero Life Sciences Ltd.

SZLSF•PNK
Healthcare
Medical - Diagnostics & Research
$0.005
$0.00(0.00%)
U.S. Market opens in 57h 56m

StageZero Life Sciences Ltd. (SZLSF) Stock Overview

Explore StageZero Life Sciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap630K
P/E Ratio-0.04
EPS (TTM)$-0.12
ROE4.82%
Fundamental Analysis

AI Price Forecasts

1 Month$0.01
3 Months$0.00
1 Year Target$0.00

SZLSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of StageZero Life Sciences Ltd. (SZLSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.04 and a market capitalization of 630K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
920.00%
3-Month Change
920.00%
6-Month Change
N/A
Year-to-Date (YTD) Change
920.00%
1-Year Change
70.00%
3-Year Change
-91.10%
5-Year Change
-99.38%
All-Time (Max) Change
-99.81%

Contact Information

https://www.stagezerolifesciences.com
NaN
70 East Beaver Creek Road, Richmond Hill, ON, L4B 3B2

Company Facts

400 Employees
IPO DateSep 8, 2009
CountryCA
Actively Trading

Frequently Asked Questions